Berland v. The Conclave, LLC

District Court, S.D. California·Decided March 20, 2023·No. 3:20-cv-00922·Unknown

Opinion

BRIAN G. BERLAND, et. al., Case No.: 20-cv-00922-H-WVG

Petitioners, ORDER: v. (1) DENYING PAGE THE CONCLAVE, LLC, et al., RESPONDENTS’ MOTION TO Respondents. CONFIRM, IN PART, AND VACATE, IN PART, FINAL ARBITRAL AWARD; AND [Doc. No. 105]

(2) GRANTING PROGENEX’S CROSS-MOTION TO CONFIRM FINAL ARBITRAL AWARD [Doc. No. 112.]

On December 29, 2022, Respondents Dagobah LLC, Page10 Ventures, LLC, and Ryan Page (the “Page Respondents”) filed a motion requesting that the Court confirm, in part, and vacate, in part, a final award issued in arbitration on September 30, 2022 (the “Final Award”) against Petitioners Brian G. Berland, Laurita Berland, Vincent Berland, Roxane M. Blake, Aaron Bollig, Steve Burns, Troy E. Burns, Michael Carey, Patrick Carey, Michael Carpenter, Sonya Carpenter, Merrill Conant, Ross Edwards, Kevin Fralick, Tom Gawlick, Justin Jones, William Kalahurka, Jeffrey Menzie, Pamela Menzie, Progenex Investment Group, LLC, D. Paul Rittman, David Schmidt, Scott Schneider, Mark Shields, The Shields Group, LLC, Michael Speer, Dennis Stanley, Gail Stanley, Ronnie Stanley, Randy Staten, Gina Staten, Curtis L. Thomas, Nancy L. Thomas, Carol Thomeczek, William D. Turley, Sheri Turley, Gavin Unruh, Kimberly Unruh, Annetta Vahsholtz, Dennis Vahsholtz, Richard Weiser, Roger Winter, Timothy C. Winter, Jimmy Woodward, Larry Woodward, Mark Zortman, and Anita Zortman (“Petitioners”). (Doc. No. 105 (“Page Respondents’ Motion”).) On January 30, 2023, Respondent Progenex Holdings, LLC (“Progenex”) filed an opposition to the Page Respondents’ Motion and cross-moved the Court to confirm the Final Award. (Doc. No. 112 (“Progenex’s Cross-Motion”).) On January 30, 2023, Third-Party Respondent Cameron N. Verdi (“Verdi”) filed an opposition to the Page Respondents’ Motion and a response in support of Progenex’s Cross-Motion. (Doc. No. 113.) On January 31, 2023, Petitioners filed a joinder in support of Progenex’s Cross-Motion. (Doc. No. 114.) On February 17, 2023, the Page Respondents filed a consolidated opposition to Progenex’s Cross-Motion and a reply in support of their motion to confirm, in part, and vacate, in part, the Final Award. (Doc. No. 118.) On March 2, 2023, Progenex filed a reply in support of its cross-motion to confirm the Final Award. (Doc. No. 123.) The Court, pursuant to its discretion under Local Rule 7.1(d)(1), determines that the motions are fit for resolution without oral argument and submits the motions on the parties’ papers. (Doc. No. 121.) For the reasons that follow, the Court denies the Page Respondents’ Motion and grants Progenex’s Cross-Motion. These motions stem from an arbitration between the parties related to the Progenex enterprise. (Doc. No. 10-2 Ex. 1 at 3.) The Page Respondents are a group of management and holding companies and their principals who managed the Progenex enterprise. (Doc. No. 34 at 2.) Until his July 15, 2020 resignation, Respondent Ryan Page was the manager of Progenex. (Doc. No. 34-1 Ex. 1 at 6.) Petitioners are a group of passive investors in the Progenex enterprise that filed a demand for arbitration regarding various federal and state law securities claims, breach of fiduciary duty/corporate waste, and wrongful dilution. (Doc. No. 10-2 Ex. 1 at 2–3.) A. The Arbitration Agreement Petitioners initiated the arbitration pursuant to the First Amended and Restated Operating Agreement of Mercury Ventures LLC, a Wyoming limited liability company (the “Agreement”). (Doc. No. 106-3 Ex. C at 32.) The Agreement provides for “binding arbitration by a Judicial Arbitration and Mediation Service (“JAMS”) arbitrator.” (Id.) The Agreement thereby incorporates the JAMS Comprehensive Arbitration Rules and Procedures (the “JAMS Rules”). The JAMS Rules allow the Arbitrator to grant “any remedy or relief that is just and equitable and within the scope of the Parties Agreement, including, but not limited to, specific performance of a contract or any other equitable or legal remedy.” JAMS Rule 24(c). The Agreement also requires that “[t]he award shall be made within ninety (90) days from the date the arbitration proceedings are initiated.” (Id. at 32.) The parties submitted a Joint First Amended Statement of Claims that became the operative pleading in the arbitration. (Doc. No. 106-7 Ex. G.) In it, the claimants–the Petitioners in the present case–brought several causes of actions and requested, among other things: “a temporary restraining order, preliminary injunction, and permanent injunction immediately removing Page (and Shamion and Luke Adams and Paul Gomez) from any and all positions as Managers in the Progenex organization, appointing independent replacement Co-Managers, and restraining Respondents from using, selling, transferring, hypothecating or otherwise dissipating or disposing of the funds and assets transferred to them.” (Id. at 91-92.) B. The Initial Proceedings and Interim Award Petitioners initiated the underlying arbitration before JAMS on January 27, 2016. (Doc. No. 106-23 Ex. W at 2.) The Arbitrator held the arbitration hearing in March 2018. (Id.) On February 4, 2019, the Arbitrator issued an Interim Award. (Id. at 28.) In the Interim Award, the Arbitrator found that the Petitioners “have failed to prove their [i] federal and state securities law claims . . ., [ii] dilution, and [iii] breach of fiduciary duty/corporate waste claims against Respondents” (the “Original Claims”). (Id. at 3.) The Arbitrator also concluded that “while the dilution transactions were legally permissible and valid, the degree to which the passive investors were diluted . . . was inequitable.” (Id. at 22.) “[T]o ameliorate the extent of the dilution of the Passive Investor [Petitioners]’ shareholder interests in Progenex,” the Arbitrator “exercise[d] her equitable authority,” and ordered the adjustment of ownership interests in Progenex. (Id. at 3.) The Arbitrator ordered the Petitioners’ percentage interest in Progenex to be increased “51% on a pro rata basis,” which would be derived from a reduction in the interests of Aaron Thomas (“Thomas”), Verdi, River Pine LLC, and Conclave members. (Id. at 26–27.) The Arbitrator also provided that Petitioners “failed to establish that Respondents have engaged in legally actionable conduct justifying the removal of Ryan Page from his position as manager of Progenex.” (Id.) To conclude, the Interim Award stated that “[e]xcept as otherwise provided herein, all claims, counter-claims, and affirmative defenses asserted by or between any parties hereto are hereby dismissed with prejudice.” (Id. at 28.) C. Order Reopening Arbitration Hearing On July 31, 2019, the Arbitrator entered an Order Reopening the Arbitration Hearing to review allegedly new material evidence. (Doc. No. 23-2 Ex. A at 1.) The Arbitrator specified that the hearing was being reopened “for limited purposes and for a narrowly limited period of time,” and noted that the “Arbitration has been a very protracted and difficult one . . . and it must be brought to conclusion without further unnecessary delay.” (Id. at 1–2.) The Petitioners and Verdi submitted voluminous exhibits containing new evidence and the parties filed briefing regarding it. (Doc. No. 34-1 Ex. 1 at 4.) In December 2019, the Arbitrator reviewed the new evidence. (Id.) On December 20, 2019, Petitioners alerted the Arbitrator of certain “urgent developments related to the Progenex business which likely would affect the status quo of the parties and/or conservation of property and assets” related to the underlying arbitration. (Id.) Respondent Ryan Page had (1) terminated the counsel for the Progenex enterprises in various third- party litigations, resulting in default judgments, and (2) issued a multi-million dollar capital call to the shareholders of Progenex, including Petitioners. (Id.) On January 13, 2020, the Page Respondents’ counsel notified the Arbitrator of a public auction that occurred on December 30, 2019. (Id. at 5.) At the public aucti

Free access — add to your briefcase to read the full text and ask questions with AI

Berland v. The Conclave, LLC, (S.D. Cal. 2023).

Berland v. The Conclave, LLC (Berland v. The Conclave, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Buckeye Check Cashing, Inc. v. Cardegna
546 U.S. 440 (Supreme Court, 2006)
Hall Street Associates, L. L. C. v. Mattel, Inc.
552 U.S. 576 (Supreme Court, 2008)
Lagstein v. CERTAIN UNDERWRITERS, LLOYD'S, LONDON
607 F.3d 634 (Ninth Circuit, 2010)
Florasynth, Inc. v. Alfred Pickholz
750 F.2d 171 (Second Circuit, 1984)
Biller v. Toyota Motor Corp.
668 F.3d 655 (Ninth Circuit, 2012)
Oxford Health Plans LLC v. Sutter
133 S. Ct. 2064 (Supreme Court, 2013)
Qorvis Communications, LLC v. Wilson
549 F.3d 303 (Fourth Circuit, 2008)
Kevin Ferguson v. Corinthian Colleges, Inc.
733 F.3d 928 (Ninth Circuit, 2013)
Comedy Club, Inc. v. Improv West Associates
553 F.3d 1277 (Ninth Circuit, 2009)
In Re Bosack v. Soward
586 F.3d 1096 (Ninth Circuit, 2009)
Collins v. D.R. Horton, Inc.
505 F.3d 874 (Ninth Circuit, 2007)
Romero v. Citibank USA, National Ass'n
551 F. Supp. 2d 1010 (E.D. California, 2008)
Major League Baseball Players Assn. v. Garvey
532 U.S. 504 (Supreme Court, 2001)